Curtis Gale Oltmans - 09 Aug 2022 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FULC	Stock Option (right to buy)	Award	$0	+50,000		$0.000000	50,000	09 Aug 2022	Common Stock	50,000	$7.40	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option was granted on August 9, 2022 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of August 9, 2022. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service